Table 3

Individual clinical symptom measures after MRgFUS, 24-month follow-up (part 1 of 2)

MeasurePt. no.BL1 wk1 mo3 mo6 mo12 mo24 moIR at 6 mo, %IR at 12 mo, %IR at 24 mo, %
Y-BOCS*13836353229182123.752.644.7
23432271818222747.135.320.6
33531322826151425.757.160.0
43428222221221938.235.344.1
53735292827283027.024.318.9
63528292423201434.342.960.0
73420182116232152.932.438.2
83633302829272619.425.027.8
93030282727212110.030.030.0
103430302719151244.155.964.7
113130303025292919.46.56.5
Mean ± SD34.4 ± 2.330.3 ± 4.328.2 ± 4.625.9 ± 4.223.6 ± 4.521.8 ± 4.821.3 ± 6.231.1 ± 13.336.1 ± 15.337.8 ± 18.9
HAM-D12775744785.285.274.1
2181581111211538.9−16.716.7
325111312116356.076.088.0
4201061096555.070.075.0
524105915141537.541.737.5
61911101195252.673.789.5
717951011131435.323.517.6
8131086810138.523.192.3
9168101193943.881.343.8
10969626377.833.366.7
112113121610101052.452.452.4
Mean ± SD19.0 ± 5.310.0 ± 2.68.3 ± 2.89.9 ± 2.99.0 ± 3.58.9 ± 5.47.6 ± 5.352.1 ± 16.449.4 ± 31.859.4 ± 27.7
HAM-A13456644788.288.279.4
21714777191558.8−11.811.8
331131615176745.280.677.4
42697854580.884.680.8
51910885151473.721.126.3
62191112136238.171.490.5
717109148121052.929.441.2
8208101489760.055.065.0
9209191885760.075.065.0
1016711635481.368.875.0
1125202221159940.064.064.0
Mean ± SD22.4 ± 5.910.4 ± 4.111.5 ± 5.311.3 ± 5.18.5 ± 4.68.6 ± 4.97.9 ± 3.961.7 ± 17.356.9 ± 31.361.5 ± 24.7
GAF§1304040535533.376.783.3
2354545364228.62.920.0
3304043696943.3130.0130.0
4334351555554.666.766.7
5324040374025.015.625.0
6334545606536.481.897.0
7424858555538.131.031.0
8394343485010.323.128.2
9435155656527.951.251.2
10354760657071.485.7100.0
11424548505014.319.019.0
Mean ± SD35.8 ± 4.944.3 ± 3.648.0 ± 7.153.9 ± 10.856.0 ± 10.334.8 ± 17.453.1 ± 38.859.2 ± 38.6
CGI-S17775544
26654445
36665433
46544444
57765555
66554443
77544444
86665544
95554444
106564432
115555555
Mean ± SD6.1 ± 0.25.6 ± 0.25.4 ± 0.34.5 ± 0.24.4 ± 0.24.0 ± 0.23.9 ± 0.3
CGI-I**1443312
2432223
3342211
4322222
5433333
6332221
7212122
8443322
9444322
10233211
11444444
Mean ± SD3.4 ± 0.23.2 ± 0.32.7 ± 0.22.5 ± 0.22.0 ± 0.32.1 ± 0.3
  • BL = baseline; CGI-I = Clinical Global Impression–Improvement; CGI-S = Clinical Global Impression–Severity; GAF = Global Assessment of Functioning; HAM-A = Hamilton Rating Scale for Anxiety; HAM-D = Hamilton Rating Scale for Depression; IR = improvement rate; MRgFUS, magnetic resonance–guided focused ultrasound; SD = standard deviation; Y-BOCS = Yale–Brown Obsessive Compulsive Disorder Scale.

  • * Mean Y-BOCS scores decreased significantly across the 24-month follow-up period (linear mixed model; F6,10.0 = 18.6, p < 0.001).

  • Mean HAM-D scores decreased significantly across the 24-month follow-up period (linear mixed model; F6,10.0 = 13.4, p < 0.001).

  • Mean HAM-A scores decreased significantly across the 24-month follow-up period (linear mixed model; F6,10.0 = 85.4, p < 0.001).

  • § Mean GAF scores increased significantly across the 24-month follow-up period (linear mixed model; F4,10.0 = 25.2, p < 0.001).

  • Mean CGI-S scores decreased significantly across the 24-month follow-up period (linear mixed model; F6,10.0 = 11.3, p = 0.001).

  • ** Mean CGI-I scores decreased significantly across the 24-month follow-up period (linear mixed model; F5,10.0 = 13.3, p < 0.001).